Issue link: http://osercommunicationsgroup.uberflip.com/i/562613
C h a i n D r u g s t o r e D a i l y 1 7 M o n d a y, A u g u s t 2 4 , 2 0 1 5 FOUR MILLION PINK, GUN OIL SAMPLES DISTRIBUTED BY EMPOWERED PRODUCTS Empowered Products, Inc., a U.S.-based manufacturer of sexual wellness products under its award-winning PINK ® and Gun Oil ® brands, ran its broadest consumer advertising campaign to date in time for Valentine's Day to support more than 24,000 U.S. retail locations carrying its products. The campaign to more than 22.5 mil- lion households commenced the week of January 25 with publication of manufac- turer's coupons in SmartSource ® free- standing insert (FSI) circulars in the Sunday and weekly neighborhood edi- tions of newspapers serving New York City metro, Philadelphia, Pittsburgh, Washington, DC, Detroit, Cincinnati, Chicago, Milwaukee, Green Bay, Dallas/Fort Worth metro, Austin, Houston, San Antonio, Seattle, Los Angeles, Portland, Oregon, Boston, and Providence, Rhode Island. The goal of the campaign is to encourage consumers to visit their favorite Walgreens, CVS, Walmart, Rite Aid, Kroger, Fred Meyer, Roundy's and HEB stores to redeem the coupons for PINK and Gun Oil products. Empowered Products also continued its ongoing commit- ment to supporting safe sex education workshops and events through university sponsored pro- grams. Empowered Products provided thousands of complimentary PINK and Gun Oil samples, as well as catalogs, dis- count cards and related items to Boston University, New College of Florida, San Francisco State University and New York University in support of their safe sex education programs and events. Since its founding in 2003, Empowered Products has distributed more than four million sample pack sachets to customers, fans, media, events and organizations around the U.S. Scott Fraser, President and Chief Executive Officer of Empowered Products, stated, "Our commitment to safe sex education is an integral com- ponent of our beneficial inter- action with current and future customers as we provide guidance for safe-sex prac- tices within a comfortable learning envi- ronment. Empowered Products stands by the empowerment of the students throughout our nation's university sys- tem and we are enriched by our improved community." To learn more about Empowered Products, visit booth #3548, go to www.empowered products.com, call 800.929.0407 or email wholesale@empoweredproducts.com. PURACAP: HIGH QUALITY IS BUILT IN When PuraCap ® pursued the develop- ment of a state-of-the-art soft gel manu- facturing plant in Wuhan, China six years ago, there were many skeptics, particu- larly with regard to quality. The PuraCap goal was to build the world-class quality in, right from the start. The plant design was state-of-the-art and FDA reviewed and approved. Management was U.S. trained. Technology was cutting edge. All systems and processes were U.S. cGMP. Although PuraCap has had many inspections by its customers and business partners, the crown jewel is the recent FDA inspection. In May 2015, the PuraCap facility underwent a full cGMP inspection. It was an intense review of every process and aspect of its Wuhan operation. It is with great pride that PuraCap announces the successful FDA inspec- tion. Not only did PuraCap pass; it did not receive any observations. For the PuraCap team, this was a great achieve- ment. For its customers, it sees this as a testament to its dedication to world-class quality. PuraCap Pharmaceutical LLC is an emerging, fully integrated pharmaceutical company with expertise in product development, manufacturing and bringing affordable, world-class quality products to its customers. The PuraCap corporate structure supports a two- pronged approach for global growth, with dedicated companies in the areas of prescription brands (PuraCap Pharmaceutical) as well as pre- scription generics and OTC and private label brands (PuraCap Laboratories). PuraCap Pharmaceutical continues to innovate using its soft gel expertise and developing other soft gel options. It is actively seeking partnership opportunities and welcomes inquiries. For more information, visit booth #3117 or contact Mark Bolling, Vice President of Sales and Marketing, OTC at Mark.Bolling@puracap.com. IMPROVE MEMORY, CONCENTRATION, FOCUS WITH FOCUSFACTOR Synergy CHC Corp was founded in 2012 under the leadership of Jack Ross, Chief Executive Officer. In January, 2015 it announced the acquisition of FOCUSfactor ® , America's No. 1 brain health supplement. FOCUSfactor is sold at more than 20,000 retail stores nation- wide, including Costco, Sam's Club, Walmart, Walgreens, The Vitamin Shoppe and the U.S. Military. FOCUSfactor is a clinically studied, patented formulation that improves mem- ory, concentration and focus. In 2012 the company was issued US Patent 8,329,227 covering FOCUSfactor's formulation "for enhanced mental function." Few nationally branded supplements have been issued patents of this nature. The company states that FOCUSfactor's pro- prietary blend of neuro-nutrients is free of preservatives and artificial colors. The all natural formula contains no ephedra and no caffeine. The issuance of the patent for FOCUSfactor came after a 2011 clinical study which proved that FOCUSfactor improves memory, concentration and focus in healthy adults. The study was conducted by Cognitive Research Corporation, a leading contract research organization specializing in the effects of nutritional supplements on human cogni- tion. According to Dr. Gary Kay, a clinical neuropsychologist and President of Cognitive Research Corporation, "the clinical study demonstrated that compared to placebo, FOCUSfactor improved abilities referred to as memory, concentration and focus in healthy adults." FOCUSfactor is debuting its new brand design and mar- keting plans. The new design utilizes bright accents on a foil label, accentuated by a silver metallic cap and its signature blue bottle. Its national direct-to-con- sumer advertising plans kicked off in July with direct response television spots in key major markets throughout the country, as well as a direct response radio test in other markets. While results are early, the company is pleased with the initial consumer response. "The consumer health care market is a $502 billion market," said Jack Ross, Chief Executive Officer of Synergy CHC Corp. "We believe growth will be driven by preventive health and wellness categories, and FOCUSfactor helps fill that niche." Retailers carrying FOCUSfactor enjoy robust retail- er-specific marketing within their four walls. The brand has proven to respond well during promotional periods and con- sumer take-away is higher than ever. For more information, visit booth #3231 or go to www.focusfactor.com. Sales inquiries should contact Jay Williams at 770.335.1675 or via email at jwilliams@inlifebdg.com. GAVIS DEDICATED TO BRINGING NICHE PRODUCTS TO MARKET FIRST Founded in 2008 by Dr. Veerappan Subramanian, GAVIS ® Pharmaceuticals develops, markets, and in conjunction with its affiliate, Novel Laboratories of Somerset, New Jersey, manufactures niche, specialty and difficult-to-make products across a range of therapeutic classes and dosage forms. GAVIS delivers value to its retail phar- macy partners by identifying the needs of patients, prescribers and pharmacies, and delivering products that offer therapeutic, economic or continuity benefits to everyone involved. Often, these are products for which no generic version is available. More Choices for Patients, Physicians and Pharmacists The company's development portfolio focuses on products for gastrointestinal, women's health and controlled drug sub- stances across a range of dosage forms, including modified-release tablets and capsules, chewable tablets, orally-disin- tegrating tablets, topical solutions and many more. Recent Product Launches GaviLyte™-H Now, less is an option. GAVIS Pharmaceuticals recently introduced GaviLyte-H as the newest addition to the GaviLyte line of bowel-prep products. This 2-liter volume PEG-3350 with bisacodyl delayed-release tablet pro- vides an alternative pre-colonoscopy prep and is now available as a value- branded generic. Comparable to HalfLytely ® , a product from Braintree Laboratories, Inc., GaviLyte-H was introduced to provide a generic 2-liter volume PEG- 3350 option to the market. GaviLyte-H comes as a complete kit combining a 2- liter container, flavor packs, GaviLyte-H powder and one Bisacodyl DR tablet. Visit www.gavilyte.com. Methylphenidate HCl Chewable Tablets, CII GAVIS Pharmaceuticals recently announced the launch of Methylphenidate HCI Chewable tablets, CII, as a generic. This chewable tablet offers an alternative for children who have difficulty swallow- ing tablets. AB-rated to Methylin ® Chewable tablets, a product produced by Mallinckrodt LLC, Methylphenidate HCl Chewable tablets offer convenient, pre- cise dosing, all in a grape flavored chew- able tablet. Methylphenidate HCl Chewable Tablets are avail- able in 2.5 mg, 5 mg and 10 mg doses. Visit www.gavis pharma.com. Doxycycline Capsules USP AB-rated to Monodox ® Doxycycline Monohydrate capsules, GAVIS's Doxycycline Capsules USP are available in 50 mg, 75 mg and 100 mg strengths. Visit www.gavispharma.com. Oxycodone Hydrochloride Oral Solution USP, 100mg/5mL GAVIS's Oxycodone Hydrochloride Oral Solution USP, 100 mg/5 mL is AB-rated to Oxycodone Hydrochloride Oral Solution USP, 100 mg/5 mL, of Lehigh Valley Technologies, Inc. Visit www.gavisphar- ma.com. Visit GAVIS at booth #2313. For more information, call 908.603.6080 or go to www.gavispharma.com.